Michael Isenhour Begins Chemotherapy

Michael Isenhour's senior basketball season ended suddenly this week when he was diagnosed with acute lypmhatic leukemia and began five to six weeks of chemotherapy treatments at Emory University Hospital in Atlanta.

Michael Isenhour's senior basketball season ended suddenly this week when he was diagnosed with acute lymphatic leukemia and began five to six weeks of chemotherapy treatments at Emory University Hospital in Atlanta.

After experiencing swollen glands and fever, a physical examination and biopsy revealed extremely high white blood cell counts. Following further tests at the Georgia Tech student health center and Piedmont Hospital, he was admitted to Emory Tuesday.

Since transferring to Tech from Air Force Academy, Isenhour, a 6-8 center, had become a regular contributor in Coach Paul Hewitt's ten man rotation and was being counted on to play significant minutes again this year and help young, inexperienced players develop. He averaged about ten minutes a game last year despite a nerve condition in his right leg that limited his minutes toward the end of the season.

Isenhour is majoring in mechanical engineering and is a member of  Tech's student advisory board. He is scheduled to graduate in December and Coach Hewitt is hoping they can keep him on track for his degree.


GoJackets.com Top Stories